<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Chatton JY</dc:creator>
  <dc:creator>Pellerin L</dc:creator>
  <dc:creator>Magistretti PJ</dc:creator>
  <dc:date>2003</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Synaptically released glutamate has been identified as a signal coupling excitatory neuronal activity to increased glucose utilization. The proposed mechanism of this coupling involves glutamate uptake into astrocytes resulting in increased intracellular Na+ (Nai+) and activation of the Na+/K+-ATPase. Increased metabolic demand linked to disruption of Nai+ homeostasis activates glucose uptake and glycolysis in astrocytes. Here, we have examined whether a similar neurometabolic coupling could operate for the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), also taken up by Na+-dependent transporters into astrocytes. Thus, we have compared the Nai+ response to GABA and glutamate in mouse astrocytes by microspectrofluorimetry. The Nai+ response to GABA consisted of a rapid rise of 4-6 mM followed by a plateau that did not, however, significantly activate the pump. Indeed, the GABA transporter-evoked Na+ influxes are transient in nature, almost totally shutting off within approximately 30 sec of GABA application. The metabolic consequences of the GABA-induced Nai+ response were evaluated by monitoring cellular ATP changes indirectly in single cells and measuring 2-deoxyglucose uptake in astrocyte populations. Both approaches showed that, whereas glutamate induced a robust metabolic response in astrocytes (decreased ATP levels and glucose uptake stimulation), GABA did not cause any measurable metabolic response, consistent with the Nai+ measurements. Results indicate that GABA does not couple inhibitory neuronal activity with glucose utilization, as does glutamate for excitatory neurotransmission, and suggest that GABA-mediated synaptic transmission does not contribute directly to brain imaging signals based on deoxyglucose.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/189525</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1073/pnas.2132096100</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/14530410</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Proceedings of the National Academy of Sciences of the United States of America. - 2003</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Astrocytes</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Biological Transport, Active</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Brain</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Cells, Cultured</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Deoxyglucose</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Glutamic Acid</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Intracellular Fluid</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Lactic Acid</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Magnesium</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Mice</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Nipecotic Acids</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Pyridines</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Sodium</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Sodium-Potassium-Exchanging ATPase</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Synaptic Transmission</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">gamma-Aminobutyric Acid</dc:subject>
  <dc:title xmlns:ns18="xml" ns18:lang="en">GABA uptake into astrocytes is not associated with significant metabolic cost: implications for brain imaging of inhibitory transmission.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
